Concept

Antidepressant discontinuation syndrome

Related publications (23)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Antidepressant discontinuation syndrome

Graph Chatbot

Chat with Graph Search

Elucidating and modulating regulatory pathways so as to reprogram the immunosuppressive tumor microenvironment for therapeutic benefit

Highly Sensitive Detection of the Antidepressant Fluoxetine With an Extended Gate Field Effect Transistor

Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome

Sensing serotonin secreted from human serotonergic neurons using aptamer-modified nanopipettes

Metabolic signature in nucleus accumbens for anti-depressant-like effects of acetyl-L-carnitine

Combinatorial targeting of angiogenesis with inducers of autophagy in the treatment of glioblastoma multiforme

Modeling and treatment optimization of pharmaceutically active compounds by the photo-Fenton process: The case of the antidepressant Venlafaxine

Solar photo-Fenton and UV/H2O2 processes against the antidepressant Venlafaxine in urban wastewaters and human urine. Intermediates formation and biodegradability assessment

Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression

The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression